დამატებით 700-მდე მედიკამენტზე ფასების ზედა ზღვარი განისაზღვრა - რა ტიპის წამლებს შეეხება ცვლილება?. 

Detected Manipulations & Suggested Changes

Omission of key information

Leaving out important contextual details that are necessary for readers to fully understand the issue.

The article states that the Ministry will set reference prices for about 700 medicines and that sector representatives can submit opinions, but it does not specify: - Which exact types or categories of medicines are affected (beyond the headline question), - How the reference prices will be calculated, - What the expected impact on prices, availability, or quality might be, - Any potential risks (e.g., shortages, reduced assortment), - Any critical or alternative views from affected parties. The text ends with the question: "რა ტიპის მედიკამენტებზე წესდება ფასის ზედა ზღვარი" but does not actually answer it in the provided content.

5 suggestions

Add a clear list or description of the medicine categories affected (e.g., chronic disease drugs, antibiotics, over-the-counter vs prescription).

Explain briefly how reference prices are determined (e.g., based on regional price comparisons, average wholesale prices, etc.).

Include information on expected benefits and possible downsides, supported by data or expert analysis (e.g., impact on average patient spending, risk of shortages).

Answer explicitly the headline question within the body: specify what types of medicines will have upper price limits and from when.

Clarify the timeline and implementation mechanism (when the new prices take effect, how enforcement will work).

Unbalanced reporting

Presenting mainly one side’s perspective while neglecting other relevant viewpoints.

The article relies entirely on information from the Health Ministry: "ამის შესახებ ინფორმაციას ჯანდაცვის სამინისტრო ავრცელებს" and "აღნიშნულია სამინისტროს ინფორმაციაში". It mentions that sector representatives can submit their opinions, but does not include any direct quotes, reactions, or concerns from pharmaceutical companies, associations, pharmacists, doctors, or patient groups. This makes the piece functionally a one-sided relay of the Ministry’s position.

4 suggestions

Include direct quotes or summarized positions from pharmaceutical companies or their associations about the planned price caps (support, concerns, conditions).

Add comments from independent health economists or policy experts evaluating the measure’s likely impact.

Include at least one patient or patient organization perspective on medicine affordability and access.

Clarify if any stakeholders oppose or criticize the measure and present their arguments alongside the Ministry’s rationale.

Selective use of sources

Relying on a single type of source, which can skew the narrative even without explicit bias in wording.

All information is attributed to the Health Ministry and its officials (e.g., mention of the Strategic Development and Analytics Department head). No external or independent sources are cited. This selection of sources implicitly privileges the official narrative and may omit relevant critical or contextual information.

3 suggestions

Supplement the Ministry’s statement with data from independent statistical agencies, watchdogs, or international organizations on medicine prices in the country.

Quote at least one representative from the pharmaceutical sector and one independent expert to balance the official view.

If alternative sources were contacted but declined to comment, state this explicitly to show an attempt at balance.

Misleading headline (partial)

A headline that poses a question or implies information that is not fully answered or supported in the article body.

Headline: "დამატებით 700-მდე მედიკამენტზე ფასების ზედა ზღვარი განისაზღვრა - რა ტიპის წამლებს შეეხება ცვლილება?" The body of the article, as provided, does not actually specify what types of medicines are affected, despite the headline promising to answer this question. This creates a mild form of clickbait/misleading expectation.

3 suggestions

Either add a clear section in the article that explicitly lists or describes the types of medicines affected, directly answering the headline question.

Or adjust the headline to reflect the actual content, e.g., "დამატებით 700-მდე მედიკამენტზე ფასების ზედა ზღვარი განისაზღვრა – დეტალები მოგვიანებით გახდება ცნობილი" if details are not yet available.

Ensure future headlines do not promise specific information (e.g., "რა ტიპის წამლებს შეეხება") unless that information is clearly provided in the text.